Question:
For drug substances with highly variable pharmacokinetic characteristics the following Bioequivalence study design is used
For drug substances with highly variable pharmacokinetic characteristics the following Bioequivalence study design is used
Updated On: Aug 11, 2024
- Parallel Design
- Non-Replicate Design
- Non-Parallel Design
- Replicate Design
Hide Solution
Verified By Collegedunia
The Correct Option is D
Solution and Explanation
The correct option is (D) : Replicate Design
Was this answer helpful?
0
0
Top Questions on Bio-pharmaceutics
- Histogram can be drawn only for:
- GPAT - 2024
- Biopharmaceutics and Pharmacokinetics
- Bio-pharmaceutics
- Which of the following is an example of physical incompatibility:
- GPAT - 2024
- Biopharmaceutics and Pharmacokinetics
- Bio-pharmaceutics
- Histogram can be drawn only for:
- GPAT - 2024
- Biopharmaceutics and Pharmacokinetics
- Bio-pharmaceutics
- Which of the following is an example of physical incompatibility:
- GPAT - 2024
- Biopharmaceutics and Pharmacokinetics
- Bio-pharmaceutics
- A 70 kg woman was administered 1000 mg of the drug as i.v. bolus. After its uniform distribution in the body, the plasma concentration of the drug was found to be 50 mg/L. What is its volume of distribution?
- GPAT - 2023
- Biopharmaceutics and Pharmacokinetics
- Bio-pharmaceutics
View More Questions
Questions Asked in GPAT exam
- Core tablet coated with cellulose acetate phthalate has been administered to a patient. Where do you expect the drug to be released:
- GPAT - 2024
- Tablets
- An elixir contains 47 % v/v alcohol, what is the proof spirit according to USP:
- GPAT - 2024
- Liquids(solutions, syrups, elixirs, spirits, aromatic water, liquid for external uses)
- Which of the following is an aryl acetic acid derivative:
- GPAT - 2024
- carbonyl compounds
- Calculate the \( \lambda_{\text{max}} \) of the following molecule:
- GPAT - 2024
- Nucleic acid: replication, transcription, splicing, translation
- The below structure represent the drug:
- GPAT - 2024
- Biogenetic pathways
View More Questions